Rongchang Chen Selected Research

Monoclonal Antibodies

1/2024	ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension.
9/2022	Early IL-17A Prevention Rather Than Late IL-17A Neutralization Attenuates Toluene Diisocyanate-Induced Mixed Granulocytic Asthma.
1/2022	Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rongchang Chen Research Topics

Disease

50	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 11/2013
26	Asthma (Bronchial Asthma) 03/2024 - 11/2018
14	Inflammation (Inflammations) 03/2024 - 01/2019
11	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 12/2014
9	COVID-19 01/2023 - 01/2020
7	Infections 11/2023 - 01/2006
6	Airway Remodeling 03/2024 - 01/2018
6	Hypoxia (Hypoxemia) 01/2024 - 01/2013
6	Pneumonia (Pneumonitis) 01/2023 - 01/2014
6	Dyspnea (Shortness of Breath) 12/2021 - 12/2014
5	Respiratory Hypersensitivity 01/2022 - 01/2019
4	Disease Progression 01/2023 - 01/2021
4	Lung Injury 06/2017 - 01/2016
3	Reperfusion Injury 11/2023 - 02/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2023 - 01/2013
3	Critical Illness (Critically Ill) 09/2023 - 07/2018
3	Fibrosis (Cirrhosis) 07/2022 - 03/2021
3	Cardiotoxicity 01/2022 - 01/2013
3	Metaplasia 01/2022 - 01/2019
3	Neoplasms (Cancer) 01/2021 - 01/2019
3	Human Influenza (Influenza) 01/2016 - 01/2011
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2016 - 07/2015
2	Sepsis (Septicemia) 11/2023 - 04/2023
2	Myocardial Infarction 11/2023 - 01/2013
2	Hypercapnia 01/2023 - 01/2017
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 01/2022
2	Chronic Bronchitis 01/2023 - 07/2021
2	Cough 01/2023 - 12/2014
2	Eosinophilia 09/2022 - 01/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2022 - 12/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2022 - 10/2017
2	Idiopathic Pulmonary Fibrosis 07/2022 - 01/2022
2	Bronchiectasis 01/2022 - 01/2020
2	Pathologic Processes 04/2021 - 02/2020
2	Diabetic Cardiomyopathies 03/2021 - 01/2020
2	Pulmonary Embolism 01/2021 - 08/2016
2	Wounds and Injuries (Trauma) 12/2020 - 01/2020
2	Occupational Asthma 11/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

9	GoldIBA 03/2023 - 04/2015
9	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 10/2022 - 01/2019
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2015
6	CollagenIBA 07/2022 - 01/2019
6	AutoantibodiesIBA 01/2022 - 01/2019
6	CytokinesIBA 03/2021 - 11/2015
6	Immunoglobulin G (IgG)IBA 01/2021 - 01/2006
5	Anti-Bacterial Agents (Antibiotics)IBA 09/2023 - 01/2011
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2017
5	ChemokinesIBA 09/2022 - 11/2015
5	AntibodiesIBA 10/2020 - 01/2006
4	Therapeutic UsesIBA 03/2024 - 01/2020
4	Interleukin-17 (Interleukin 17)IBA 02/2024 - 01/2019
4	Interleukin-6 (Interleukin 6)IBA 04/2023 - 01/2021
4	Oxygen (Dioxygen)IBA 01/2023 - 01/2018
4	SteroidsIBA 10/2022 - 01/2019
4	Immunoglobulin M (IgM)IBA 01/2021 - 01/2019
3	OvalbuminIBA 03/2024 - 09/2019
3	Monoclonal AntibodiesIBA 01/2024 - 01/2022
3	MicroRNAs (MicroRNA)IBA 01/2023 - 05/2022
3	InterleukinsIBA 09/2022 - 01/2019
3	AntigensIBA 09/2022 - 01/2019
3	Immunoglobulin E (IgE)IBA 01/2022 - 11/2018
3	Bronchodilator Agents (Bronchodilators)IBA 12/2021 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 11/2018
3	AutoantigensIBA 08/2020 - 09/2019
3	VaccinesIBA 01/2020 - 01/2011
2	GlycosidesIBA 03/2024 - 11/2015
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2022
2	Small Cytoplasmic RNAIBA 02/2024 - 01/2022
2	Air Pollutants (Pollutants, Air)IBA 11/2023 - 01/2021
2	TabletsIBA 11/2023 - 01/2011
2	Carbon DioxideIBA 09/2023 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 04/2023 - 07/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 09/2020
2	Biological FactorsIBA 01/2023 - 07/2021
2	prednylidene (Pred)IBA 01/2023 - 01/2014
2	HydrogenIBA 11/2022 - 09/2019
2	Bleomycin (Blenoxane)FDA LinkGeneric 07/2022 - 10/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2022 - 10/2017
2	EnzymesIBA 01/2022 - 03/2021
2	AntioxidantsIBA 01/2022 - 03/2021
2	Peptides (Polypeptides)IBA 01/2022 - 01/2020
2	16S Ribosomal RNAIBA 11/2020 - 01/2020
2	Butyrates (Butyrate)IBA 11/2020 - 01/2020
2	Aggrecans (Aggrecan)IBA 06/2020 - 01/2019
2	SuspensionsIBA 01/2020 - 01/2018
2	SmokeIBA 01/2020 - 11/2013
2	lipoarabinomannan (LAM)IBA 01/2020 - 01/2019
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2020 - 01/2018

Therapy/Procedure

26	Therapeutics 01/2024 - 01/2011
9	Noninvasive Ventilation 01/2024 - 01/2016
8	Artificial Respiration (Mechanical Ventilation) 09/2023 - 01/2016
5	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2019 - 01/2017
4	Drug Therapy (Chemotherapy) 09/2020 - 01/2015
4	Mechanical Ventilators (Ventilator) 01/2020 - 01/2016
3	Cannula 01/2024 - 01/2020
3	Lung Transplantation 10/2023 - 01/2021
3	Metered Dose Inhalers (Metered Dose Inhaler) 01/2020 - 01/2018
2	Exercise Therapy (Therapy, Exercise) 12/2023 - 09/2023
2	Transplantation 11/2022 - 01/2021
2	Emergency Treatment 01/2022 - 01/2018